Saturday, 12 Apr 2008 | Source: CNBC.com
A steady stream of downbeat news seemed to leave the market unmoved for most of the week -- until the bluest of the blue chips, General Electric, posted first-quarter earnings that missed Wall Street expectations by seven cents per share, and lowered its full-year guidance.
Monday, 7 Apr 2008 | Source: CNBC.com
Where's an investor to turn, surrounded by the uncertainty of dismal economic numbers and weak corporate earnings and projections?
Friday, 28 Mar 2008 | Source: CNBC.com
Ahead of the weekend, CNBC asks the experts where investors should place their bets.
Friday, 28 Mar 2008 | Source: CNBC.com
The pharmaceutical sector faces the looming "patent cliff" -- but Credit Suisse's Catherine Arnold finds lots of opportunities in the sector for the careful investor.
Tuesday, 18 Mar 2008 | Source: CNBC.com
An estimated 10 million baby boomers -- or one out of eight -- will get Alzheimer's Disease according to a new report from the Alzheimer's Association.
Thursday, 31 Jan 2008 | Source: Reuters
Wyeth Thursday forecast flat revenue and lower earnings for 2008 due to suddenly erupting generic competition for its blockbuster Protonix heartburn medicine and assumptions about possible generic competition for other medicines.
Thursday, 17 Jan 2008 | Source: The Associated Press
House Democrats are investigating whether a chemical used to package baby formulas poses a risk to infants, despite assurances by U.S. regulators that it is safe for kids and adults.
Posts |
COMPANY : Wyeth
11 Jul 2008
A few weeks ago I blogged about a couple analysts cautioning investors that shares of Irish drugmaker Elan would be volatile surrounding the Alzheimer's conference the end of this month.That has certainly proven to be the case, especially today as the second firm this week initiates coverage of the stock, but this time with a "Sell" rating.... Read More
8 Jul 2008
Some traders are also turning bullish... Read More
8 Jul 2008
At the risk of being ganged up on by the "Elanians" who will take umbrage with the fact that the biopharma team at Cowen and Company is not initiating coverage of the Irish drugmaker with a "screaming buy," I am blogging about the analysts' 50-page call on the stock today... Read More
3 Jul 2008
Ahead of the long holiday weekend I thought this would be as good a time as any to once again go through the "Pharma's Market" mailbag... Read More
VIDEO | COMPANIES : Wyeth
Wyeth CEO Bernard Poussot discusses his company's earnings and outlook with CNBC's Maria Bartiromo.
More Videos
HOME | NEWS | MARKETS | EARNINGS | INVESTING | VIDEO | CNBC TV | CNBC PLUS | CNBC HD+
About CNBC | Site Map | Privacy Policy | Terms of Service | Advertise | Help | Feedback | Video Reprints
About CNBC | Site Map | Privacy Policy | Terms of Service | Advertise | Help | Feedback | Video Reprints
Partners: AOL Money | BloggingStocks.com
(c) 2008 CNBC, Inc. All Rights Reserved
Data is a real-time snapshot *Data is delayed at least 15 minutes